Alberta Investment Management Corp (AIMCo)’s Harmony Biosciences HRMY Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,600	Closed	-$2.01M	–	723
2025 Q1	$2.01M	Buy	60,600 +22,000	+57%	+$789K	0.01%	460
2024 Q4	$1.33M	Buy	38,600 +11,800	+44%	+$405K	0.01%	558
2024 Q3	$1.07M	Buy	+26,800	New	+$941K	0.01%	559
2023 Q3	–	Sell	-42,332	Closed	-$1.49M	–	1117
2023 Q2	$1.49M	Sell	42,332 -25,536	-38%	-$882K	0.01%	629
2023 Q1	$2.22M	Buy	67,868 +104	+0.2%	+$4.74K	0.02%	522
2022 Q4	$3.73M	Buy	67,764 +9,940	+17%	+$547K	0.03%	490
2022 Q3	$2.56M	Buy	57,824 +31,472	+119%	+$1.54M	0.02%	650
2022 Q2	$1.28M	Sell	26,352 -742	-3%	-$33.4K	0.01%	819
2022 Q1	$1.32M	Buy	27,094 +14,839	+121%	+$605K	0.01%	890
2021 Q4	$523K	Buy	+12,255	New	+$488K	﹤0.01%	875

Other funds holding HRMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s HRMY Position: Q2 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of Harmony Biosciences (HRMY) in Q2 2025, closing a stake of 60,600 shares — an estimated $2.01M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in HRMY in Q4 2021 and held it in 10 quarters. The position peaked at $3.73M in Q4 2022. 279 funds tracked by Wall St. Rank hold HRMY as of Q2 2025.

Alberta Investment Management Corp (AIMCo) reported no remaining Harmony Biosciences position as of Q2 2025 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 60,600 Harmony Biosciences shares in Q2 2025, an estimated $2.01M.
Alberta Investment Management Corp (AIMCo) first reported a position in Harmony Biosciences in Q4 2021 and held it in 10 quarters.
Alberta Investment Management Corp (AIMCo)'s Harmony Biosciences position peaked at $3.73M in Q4 2022.
279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2025, filed 8 Aug 2025.